Literature DB >> 7740745

In vitro susceptibility of Campylobacter and Salmonella isolates from broilers to quinolones, ampicillin, tetracycline, and erythromycin.

W F Jacobs-Reitsma1, P M Koenraad, N M Bolder, R W Mulder.   

Abstract

Recently, an increased resistance of Campylobacter to fluoroquinolones, a newer class of antimicrobial agents in both human and veterinary medicine, has been reported. Campylobacter isolates (617) from 150 broiler flocks were tested for their susceptibility to cephalothin (control), ampicillin, tetracycline, erythromycin, and the quinolones nalidixic acid, flumequine, enrofloxacin, and ciprofloxacin by a disc diffusion method. Almost complete cross-resistance was found between the quinolones tested. Campylobacter isolates (181, 29%), originating from 55 flocks (37%), were quinolone resistant. Salmonella isolates (94) from 40 flocks were also tested for their antimicrobial susceptibility. Eight isolates (8.5%), from three broiler flocks (7.5%), showed resistance to nalidixic acid and flumequine (and tetracycline), but not to ciprofloxacin or enrofloxacin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7740745     DOI: 10.1080/01652176.1994.9694450

Source DB:  PubMed          Journal:  Vet Q        ISSN: 0165-2176            Impact factor:   3.320


  11 in total

1.  Antimicrobial susceptibilities of thermophilic Campylobacter from humans, swine, and chicken broilers.

Authors:  Evelyne Guévremont; Eric Nadeau; Marc Sirois; Sylvain Quessy
Journal:  Can J Vet Res       Date:  2006-04       Impact factor: 1.310

2.  Antimicrobial susceptibilities of Campylobacter jejuni isolates from poultry from Alberta, Canada.

Authors:  Veronica N Kos; Monika Keelan; Diane E Taylor
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

3.  Incidence of quinolone resistance over the period 1986 to 1998 in veterinary Salmonella isolates from Germany.

Authors:  B Malorny; A Schroeter; R Helmuth
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

Review 4.  The Current State of Macrolide Resistance in Campylobacter spp.: Trends and Impacts of Resistance Mechanisms.

Authors:  Hannah Bolinger; Sophia Kathariou
Journal:  Appl Environ Microbiol       Date:  2017-05-31       Impact factor: 4.792

5.  Antimicrobial susceptibility patterns of thermophilic Campylobacter spp. from humans, pigs, cattle, and broilers in Denmark.

Authors:  F M Aarestrup; E M Nielsen; M Madsen; J Engberg
Journal:  Antimicrob Agents Chemother       Date:  1997-10       Impact factor: 5.191

6.  Use of a LightCycler gyrA mutation assay for rapid identification of mutations conferring decreased susceptibility to ciprofloxacin in multiresistant Salmonella enterica serotype Typhimurium DT104 isolates.

Authors:  R A Walker; N Saunders; A J Lawson; E A Lindsay; M Dassama; L R Ward; M J Woodward; R H Davies; E Liebana; E J Threlfall
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

7.  Typing of human Campylobacter jejuni isolates in Finland by pulsed-field gel electrophoresis.

Authors:  M L Hänninen; S Pajarre; M L Klossner; H Rautelin
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

8.  Darkling beetles (Alphitobius diaperinus) and their larvae as potential vectors for the transfer of Campylobacter jejuni and Salmonella enterica serovar paratyphi B variant Java between successive broiler flocks.

Authors:  Wilma C Hazeleger; Nico M Bolder; Rijkelt R Beumer; Wilma F Jacobs-Reitsma
Journal:  Appl Environ Microbiol       Date:  2008-09-12       Impact factor: 4.792

9.  The speciation and subtyping of campylobacter isolates from sewage plants and waste water from a connected poultry abattoir using molecular techniques.

Authors:  P M Koenraad; R Ayling; W C Hazeleger; F M Rombouts; D G Newell
Journal:  Epidemiol Infect       Date:  1995-12       Impact factor: 2.451

10.  Antibiotic susceptibility of campylobacter isolates from sewage and poultry abattoir drain water.

Authors:  P M Koenraad; W F Jacobs-Reitsma; T Van der Laan; R R Beumer; F M Rombouts
Journal:  Epidemiol Infect       Date:  1995-12       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.